1
, 2
Infectious Diseases: A Clinical Short
Course – Test Bank
Edition/Reference: 4th Edition
Chapter List
1. Anti-Infective Therapy
2. Sepsis
3. The Febrile Patient
4. Pulmonary Infections
5. Eye, Ear, Nose, and Throat Infections
6. Central Nervous System Infections
7. Cardiovascular Infections
8. Gastrointestinal and Hepatobiliary Infections
9. Genitourinary Tract Infections and Sexually Transmitted Diseases
10. Skin and Soft Tissue Infections
11. Osteomyelitis, Prosthetic Joint Infections, Diabetic Foot Infections, and Septic
Arthritis
12. Parasitic Infections: A Global Challenge
13. Emerging Bacterial Infections (Including Zoonotic Pathogens and Biological
Weapons)
14. Serious Viral Illnesses in the Adult Patient
15. Infections in the Immunocompromised Host
16. HIV Infection
, 3
Chapter 1: Anti-Infective Therapy
1. In the context of Pharmacokinetic/pharmacodynamic optimization, which action
is MOST appropriate?
A. Prioritize convenience over syndrome-directed therapy
B. Discontinue monitoring once symptoms begin to improve
C. Use a syndrome-guided, patient-specific plan for
pharmacokinetic/pharmacodynamic optimization with early reassessment and
targeted refinement.
D. Avoid reassessment after initial stabilization
✅ Correct Answer: C
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for pharmacokinetic/pharmacodynamic optimization. It
emphasizes timely intervention, objective follow-up, and narrowing therapy when
new data become available. The other options are unsafe because they delay
definitive care, ignore stewardship principles, or fail to individualize management.
DIF: Moderate | TOP: Pharmacokinetic/pharmacodynamic optimization | MSC:
Clinical Application
2. In the context of Time-dependent beta-lactam dosing, which action is MOST
appropriate?
A. Rely on a single test result without clinical correlation
B. Use a syndrome-guided, patient-specific plan for time-dependent beta-lactam
dosing with early reassessment and targeted refinement.
C. Prioritize convenience over syndrome-directed therapy
D. Discontinue monitoring once symptoms begin to improve
, 4
✅ Correct Answer: B
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for time-dependent beta-lactam dosing. It emphasizes
timely intervention, objective follow-up, and narrowing therapy when new data
become available. The other options are unsafe because they delay definitive care,
ignore stewardship principles, or fail to individualize management.
DIF: Moderate | TOP: Time-dependent beta-lactam dosing | MSC: Clinical
Application
3. In the context of Concentration-dependent aminoglycoside dosing, which action
is MOST appropriate?
A. Use a syndrome-guided, patient-specific plan for concentration-dependent
aminoglycoside dosing with early reassessment and targeted refinement.
B. Discontinue monitoring once symptoms begin to improve
C. Rely on a single test result without clinical correlation
D. Deferr source control while escalating antimicrobial doses
✅ Correct Answer: A
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for concentration-dependent aminoglycoside dosing. It
emphasizes timely intervention, objective follow-up, and narrowing therapy when
new data become available. The other options are unsafe because they delay
definitive care, ignore stewardship principles, or fail to individualize management.
DIF: Difficult | TOP: Concentration-dependent aminoglycoside dosing | MSC:
Clinical Application
4. In the context of Vancomycin AUC-guided monitoring, which action is MOST
appropriate?
, 5
A. Rely on a single test result without clinical correlation
B. Deferr source control while escalating antimicrobial doses
C. Assume colonization and infection are always equivalent
D. Use a syndrome-guided, patient-specific plan for vancomycin auc-guided
monitoring with early reassessment and targeted refinement.
✅ Correct Answer: D
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for vancomycin auc-guided monitoring. It emphasizes
timely intervention, objective follow-up, and narrowing therapy when new data
become available. The other options are unsafe because they delay definitive care,
ignore stewardship principles, or fail to individualize management.
DIF: Moderate | TOP: Vancomycin AUC-guided monitoring | MSC: Clinical
Application
5. In the context of Renal dose adjustment principles, which action is MOST
appropriate?
A. Assume colonization and infection are always equivalent
B. Select therapy without considering organ function
C. Use a syndrome-guided, patient-specific plan for renal dose adjustment
principles with early reassessment and targeted refinement.
D. Deferr source control while escalating antimicrobial doses
✅ Correct Answer: C
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for renal dose adjustment principles. It emphasizes
timely intervention, objective follow-up, and narrowing therapy when new data
, 6
become available. The other options are unsafe because they delay definitive care,
ignore stewardship principles, or fail to individualize management.
DIF: Easy | TOP: Renal dose adjustment principles | MSC: Clinical Application
6. In the context of Oral step-down therapy criteria, which action is MOST
appropriate?
A. Ignore local resistance patterns when choosing empiric therapy
B. Use a syndrome-guided, patient-specific plan for oral step-down therapy
criteria with early reassessment and targeted refinement.
C. Assume colonization and infection are always equivalent
D. Select therapy without considering organ function
✅ Correct Answer: B
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for oral step-down therapy criteria. It emphasizes timely
intervention, objective follow-up, and narrowing therapy when new data become
available. The other options are unsafe because they delay definitive care, ignore
stewardship principles, or fail to individualize management.
DIF: Difficult | TOP: Oral step-down therapy criteria | MSC: Clinical Application
7. In the context of Combination therapy indications, which action is MOST
appropriate?
A. Use a syndrome-guided, patient-specific plan for combination therapy
indications with early reassessment and targeted refinement.
B. Select therapy without considering organ function
C. Ignore local resistance patterns when choosing empiric therapy
D. Delay treatment until all cultures finalize
, 7
✅ Correct Answer: A
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for combination therapy indications. It emphasizes
timely intervention, objective follow-up, and narrowing therapy when new data
become available. The other options are unsafe because they delay definitive care,
ignore stewardship principles, or fail to individualize management.
DIF: Moderate | TOP: Combination therapy indications | MSC: Clinical
Application
8. In the context of Antimicrobial stewardship core elements, which action is
MOST appropriate?
A. Ignore local resistance patterns when choosing empiric therapy
B. Delay treatment until all cultures finalize
C. Use the broadest regimen for the full course regardless of response
D. Use a syndrome-guided, patient-specific plan for antimicrobial stewardship
core elements with early reassessment and targeted refinement.
✅ Correct Answer: D
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for antimicrobial stewardship core elements. It
emphasizes timely intervention, objective follow-up, and narrowing therapy when
new data become available. The other options are unsafe because they delay
definitive care, ignore stewardship principles, or fail to individualize management.
DIF: Moderate | TOP: Antimicrobial stewardship core elements | MSC: Clinical
Application
9. In the context of De-escalation after culture data, which action is MOST
appropriate?
, 8
A. Use the broadest regimen for the full course regardless of response
B. Avoid reassessment after initial stabilization
C. Use a syndrome-guided, patient-specific plan for de-escalation after culture
data with early reassessment and targeted refinement.
D. Delay treatment until all cultures finalize
✅ Correct Answer: C
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for de-escalation after culture data. It emphasizes timely
intervention, objective follow-up, and narrowing therapy when new data become
available. The other options are unsafe because they delay definitive care, ignore
stewardship principles, or fail to individualize management.
DIF: Difficult | TOP: De-escalation after culture data | MSC: Clinical Application
10. In the context of Source control and antibiotic success, which action is MOST
appropriate?
A. Prioritize convenience over syndrome-directed therapy
B. Use a syndrome-guided, patient-specific plan for source control and
antibiotic success with early reassessment and targeted refinement.
C. Use the broadest regimen for the full course regardless of response
D. Avoid reassessment after initial stabilization
✅ Correct Answer: B
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for source control and antibiotic success. It emphasizes
timely intervention, objective follow-up, and narrowing therapy when new data
become available. The other options are unsafe because they delay definitive care,
ignore stewardship principles, or fail to individualize management.
, 2
Infectious Diseases: A Clinical Short
Course – Test Bank
Edition/Reference: 4th Edition
Chapter List
1. Anti-Infective Therapy
2. Sepsis
3. The Febrile Patient
4. Pulmonary Infections
5. Eye, Ear, Nose, and Throat Infections
6. Central Nervous System Infections
7. Cardiovascular Infections
8. Gastrointestinal and Hepatobiliary Infections
9. Genitourinary Tract Infections and Sexually Transmitted Diseases
10. Skin and Soft Tissue Infections
11. Osteomyelitis, Prosthetic Joint Infections, Diabetic Foot Infections, and Septic
Arthritis
12. Parasitic Infections: A Global Challenge
13. Emerging Bacterial Infections (Including Zoonotic Pathogens and Biological
Weapons)
14. Serious Viral Illnesses in the Adult Patient
15. Infections in the Immunocompromised Host
16. HIV Infection
, 3
Chapter 1: Anti-Infective Therapy
1. In the context of Pharmacokinetic/pharmacodynamic optimization, which action
is MOST appropriate?
A. Prioritize convenience over syndrome-directed therapy
B. Discontinue monitoring once symptoms begin to improve
C. Use a syndrome-guided, patient-specific plan for
pharmacokinetic/pharmacodynamic optimization with early reassessment and
targeted refinement.
D. Avoid reassessment after initial stabilization
✅ Correct Answer: C
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for pharmacokinetic/pharmacodynamic optimization. It
emphasizes timely intervention, objective follow-up, and narrowing therapy when
new data become available. The other options are unsafe because they delay
definitive care, ignore stewardship principles, or fail to individualize management.
DIF: Moderate | TOP: Pharmacokinetic/pharmacodynamic optimization | MSC:
Clinical Application
2. In the context of Time-dependent beta-lactam dosing, which action is MOST
appropriate?
A. Rely on a single test result without clinical correlation
B. Use a syndrome-guided, patient-specific plan for time-dependent beta-lactam
dosing with early reassessment and targeted refinement.
C. Prioritize convenience over syndrome-directed therapy
D. Discontinue monitoring once symptoms begin to improve
, 4
✅ Correct Answer: B
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for time-dependent beta-lactam dosing. It emphasizes
timely intervention, objective follow-up, and narrowing therapy when new data
become available. The other options are unsafe because they delay definitive care,
ignore stewardship principles, or fail to individualize management.
DIF: Moderate | TOP: Time-dependent beta-lactam dosing | MSC: Clinical
Application
3. In the context of Concentration-dependent aminoglycoside dosing, which action
is MOST appropriate?
A. Use a syndrome-guided, patient-specific plan for concentration-dependent
aminoglycoside dosing with early reassessment and targeted refinement.
B. Discontinue monitoring once symptoms begin to improve
C. Rely on a single test result without clinical correlation
D. Deferr source control while escalating antimicrobial doses
✅ Correct Answer: A
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for concentration-dependent aminoglycoside dosing. It
emphasizes timely intervention, objective follow-up, and narrowing therapy when
new data become available. The other options are unsafe because they delay
definitive care, ignore stewardship principles, or fail to individualize management.
DIF: Difficult | TOP: Concentration-dependent aminoglycoside dosing | MSC:
Clinical Application
4. In the context of Vancomycin AUC-guided monitoring, which action is MOST
appropriate?
, 5
A. Rely on a single test result without clinical correlation
B. Deferr source control while escalating antimicrobial doses
C. Assume colonization and infection are always equivalent
D. Use a syndrome-guided, patient-specific plan for vancomycin auc-guided
monitoring with early reassessment and targeted refinement.
✅ Correct Answer: D
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for vancomycin auc-guided monitoring. It emphasizes
timely intervention, objective follow-up, and narrowing therapy when new data
become available. The other options are unsafe because they delay definitive care,
ignore stewardship principles, or fail to individualize management.
DIF: Moderate | TOP: Vancomycin AUC-guided monitoring | MSC: Clinical
Application
5. In the context of Renal dose adjustment principles, which action is MOST
appropriate?
A. Assume colonization and infection are always equivalent
B. Select therapy without considering organ function
C. Use a syndrome-guided, patient-specific plan for renal dose adjustment
principles with early reassessment and targeted refinement.
D. Deferr source control while escalating antimicrobial doses
✅ Correct Answer: C
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for renal dose adjustment principles. It emphasizes
timely intervention, objective follow-up, and narrowing therapy when new data
, 6
become available. The other options are unsafe because they delay definitive care,
ignore stewardship principles, or fail to individualize management.
DIF: Easy | TOP: Renal dose adjustment principles | MSC: Clinical Application
6. In the context of Oral step-down therapy criteria, which action is MOST
appropriate?
A. Ignore local resistance patterns when choosing empiric therapy
B. Use a syndrome-guided, patient-specific plan for oral step-down therapy
criteria with early reassessment and targeted refinement.
C. Assume colonization and infection are always equivalent
D. Select therapy without considering organ function
✅ Correct Answer: B
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for oral step-down therapy criteria. It emphasizes timely
intervention, objective follow-up, and narrowing therapy when new data become
available. The other options are unsafe because they delay definitive care, ignore
stewardship principles, or fail to individualize management.
DIF: Difficult | TOP: Oral step-down therapy criteria | MSC: Clinical Application
7. In the context of Combination therapy indications, which action is MOST
appropriate?
A. Use a syndrome-guided, patient-specific plan for combination therapy
indications with early reassessment and targeted refinement.
B. Select therapy without considering organ function
C. Ignore local resistance patterns when choosing empiric therapy
D. Delay treatment until all cultures finalize
, 7
✅ Correct Answer: A
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for combination therapy indications. It emphasizes
timely intervention, objective follow-up, and narrowing therapy when new data
become available. The other options are unsafe because they delay definitive care,
ignore stewardship principles, or fail to individualize management.
DIF: Moderate | TOP: Combination therapy indications | MSC: Clinical
Application
8. In the context of Antimicrobial stewardship core elements, which action is
MOST appropriate?
A. Ignore local resistance patterns when choosing empiric therapy
B. Delay treatment until all cultures finalize
C. Use the broadest regimen for the full course regardless of response
D. Use a syndrome-guided, patient-specific plan for antimicrobial stewardship
core elements with early reassessment and targeted refinement.
✅ Correct Answer: D
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for antimicrobial stewardship core elements. It
emphasizes timely intervention, objective follow-up, and narrowing therapy when
new data become available. The other options are unsafe because they delay
definitive care, ignore stewardship principles, or fail to individualize management.
DIF: Moderate | TOP: Antimicrobial stewardship core elements | MSC: Clinical
Application
9. In the context of De-escalation after culture data, which action is MOST
appropriate?
, 8
A. Use the broadest regimen for the full course regardless of response
B. Avoid reassessment after initial stabilization
C. Use a syndrome-guided, patient-specific plan for de-escalation after culture
data with early reassessment and targeted refinement.
D. Delay treatment until all cultures finalize
✅ Correct Answer: C
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for de-escalation after culture data. It emphasizes timely
intervention, objective follow-up, and narrowing therapy when new data become
available. The other options are unsafe because they delay definitive care, ignore
stewardship principles, or fail to individualize management.
DIF: Difficult | TOP: De-escalation after culture data | MSC: Clinical Application
10. In the context of Source control and antibiotic success, which action is MOST
appropriate?
A. Prioritize convenience over syndrome-directed therapy
B. Use a syndrome-guided, patient-specific plan for source control and
antibiotic success with early reassessment and targeted refinement.
C. Use the broadest regimen for the full course regardless of response
D. Avoid reassessment after initial stabilization
✅ Correct Answer: B
Rationale: The best choice links diagnosis, host factors, and probable pathogen
behavior to a focused plan for source control and antibiotic success. It emphasizes
timely intervention, objective follow-up, and narrowing therapy when new data
become available. The other options are unsafe because they delay definitive care,
ignore stewardship principles, or fail to individualize management.
